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1. Introduction  
Peanut allergy is one of the most widespread and severe IgE-mediated food allergies, with an 
estimated prevalence of 1% in children and 0.6% in adults within the general population of 
developed countries (Ben-Shoshan et al., 2010; Sicherer and Wood 2013). The complex allergome 
of peanut consists of several type I protein allergens triggering immune responses with different 
symptoms and prognosis, depending on characteristics of the offending protein (Vereda et al. 2011, 
Lauer et al. 2009, Nicolaou and Custovic 2011, Mittag et al. 2004). Ara h 1, Ara h 2, and Ara h 3 
are major allergens associated with primary sensitization to peanut (Mueller et al. 2014). Ara h 1 is 
a 63.5-kDa vicilin-type (7S) seed storage protein, representative of the cupin superfamily, which 
naturally occurs as up to 600-700 kDa non-covalent aggregates (van Boxtel et al, 2006). Ara h 3 is a 
glycinin-like protein (11S) consisting of a 60-kDa polypeptide post-translationally cleaved in acid 
and basic subunits which remain linked each other by a disulphide bond, similarly to the 11S plant 
seed storage protein signature (Boldt et al. 2005). Ara h 2 belongs to the conglutenin (2S albumin) 
superfamily and their folding resembles that of α-amylase/trypsin inhibitors from cereal kernels 
(Mueller et al. 2011). Ara h 2 comprises two isoforms, namely Ara h 2.01 (17-kDa) and Ara h 2.02 
(19-kDa). Ara h 2.02 includes an insertion of 12 extra amino acid residues, constituting an 
additional IgE-binding epitope and is a more effective IgE cross-linker than Ara h 2.01 (Chatel et al 
2003). Ara h 6 is a 14.5-kDa 2S albumin co-member, sharing 59 % sequence identity, secondary 
and tertiary structure homology as well as immune cross-reactivity patterns with Ara h 2 
(Koppelman et al, 2005; Lehmann et al. 2006). World Health Organization and International Union 
of Immunologic Societies Subcommittee (WHO/IUIS) catalogued several additional minor peanut 
allergens (www.allergen.org), including Ara h 5 (profilin), Ara h 8 (Bet v 1birch pollen 
homologue), Ara h 9 or lipid transfer protein (LTP), the latter being a relevant peanut allergen 
especially in the Mediterranean area (Krause et al. 2009). Ara h 10 (oleosin 1) and Ara h 11 
(oroleosins) are not usually associated with severe allergic reactions (Zhuang and Dreskin 2013).   
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Apart from geographical differences in the sensitization profiles (Sicherer and Wood 2013), 
conglutenin Ara h 2 and Ara h 6 have been proven as the most harmful for peanut allergic subjects, 
in term of basophil activation, IgE-binding properties and skin prick test (Burks et al. 1991, Blanc et 
al. 2009). Both Ara h 2 and Ara h 6 are tightly coiled, heat-stable and resistant to gastrointestinal 
digestion (Suhr et al. 2004), which are structural features shared by a large number of common food 
allergens (Astwood et al. 1996). Early studies showed that digestion of Ara h 2 and Ara h 6 by 
pepsin and/or chymotrysin produce large stable fragments with unmodified immunological potential 
(Apostolovic et al. 2016). On the contrary, peanut allergen Ara h 1 and Ara h 3 have been described 
as highly susceptible to proteases (Koppelman et al. 2010). Nevertheless, peptides resulting from 
gastro-duodenal digestion of Ara h 1 retain T cell stimulatory, sensitizing capability and IgE-
binding properties (Eiwegger et al. 2006, Bøgh et al. 2009), probably due to the formation of 
exceptionally stable non-covalent peptide aggregates (Bøgh et al. 2012).  
Susceptibility of peanut food allergens to proteolysis has been typically assayed by using single 
purified proteins (Bøgh and Madsen 2016), due to the drawbacks of analyzing the heterogeneous 
digestome of peanut as a whole food. Such an approach could suffer from scarce relevance, since 
the protein aggregation state, the interaction of allergens with non-protein components naturally 
occurring in whole foodstuff (e.g. polysaccharide, lipid), presence of protease inhibitors and the 
protein-protein interactions affect the accessibility of proteases to allergens, thereby contributing to 
the bioaccessibility and hence to the bioavailability of allergenic determinants (epitopes) (Teuber 
2002). Nowadays, the advances in “omic” sciences (i.e., proteomics, metabolomics, lipidomics) 
have enabled the assessment of the food digestome as well as the identification of stable allergens 
and the monitoring of IgE-binding epitopes sequentially released upon digestion of complex 
matrices (Picariello et al. 2011, Picariello et al. 2013).  
Another relevant aspect, barely addressed so far, is the analysis of peptide fragments arising from 
the proteolysis process. In fact, the majority of the studies aimed at assessing the digestion stability 
of allergens only monitored the degradation of allergens by SDS-PAGE and Western Blot, 
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neglecting the release of immunologically active proteolytic peptides, which escape the 
electrophoretic detection. Mapping the peanut resistant peptides harbouring IgE epitopes might 
improve the knowledge about the allergenic determinants and the pathogenic mechanism, paving 
the way to new immunotherapeutic approaches (Bannon et al. 2001, Li. et al 2003). These 
considerations prompted us to simulate the digestion of whole raw peanuts using an in vitro 
multicompartmental static digestion model with physiological relevance (Minekus et al., 2014), 
which includes the oral, gastric, duodenal and intestinal phases. IgE-binding (poly)peptides 
resulting from digestion were characterized by integrated proteomic/peptidomic and 
immunochemical assays.  
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2. Materials and Methods 
2.1 Chemicals 
Raw peanuts (Virginia variety) were provided by Besana (Milano, Italy). HPLC-grade solvents 
were from Merck (Whitehouse Station, NJ, USA). Pepsin, trypsin, chymotrypsin, dithiothreitol 
(DTT), iodoacetamide (IAA), Tris-HCl, urea, guanidine chloride, ammonium bicarbonate (Ambic), 
phospholipids, trichloroacetic (TCA), trifluoroacetic (TFA), p-toluene-sulfonyl-L-arginine methyl 
ester (TAME) and the modified Lowry assay kit were purchased from Sigma-Aldrich (St Louis, 
MO, USA). Egg lecithin was from Lipid Products (Redhill, UK). Reagents for electrophoresis 
analysis were from Bio-Rad (Milan, Italy). Brush border membrane (BBM) vesicles were purified 
from porcine jejunum according to Cheeseman and O'Neill, 2006, as previously detailed (Picariello 
et al. 2015). The aminopeptidase activity was determined by colorimetric assay using p-nitroaniline 
as the substrate, while the total activity of BBM peptidases was assayed by HPLC using angiotensin 
I as a substrate (Picariello et al. 2015). 
 
2.2 Sera of peanut allergic patients  
Sera were collected from peanut allergic subjects (N=8, 80% male), all from Regione Campania 
(Southern Italy), according to the ethical requirements. The local Ethics Committee approved the 
study. The allergy symptoms ranged from urticaria to angioedema and anaphylaxis. The clinical 
features of the allergic individuals enrolled in this study are reported in Table S1. Diagnosis of IgE-
mediated allergy to peanut was confirmed by skin prick test (SPT) and oral food challenges. Either 
a SPT peanut extract or fresh peanut (prick-by-prick) was applied to the patients’ volar forearm. 
Tests were performed using a 1-mm single peak lancet (ALK, Copenhagen, Denmark), with 
histamine dihydrochloride (10 mg/mL) and isotonic saline solution (0.9% NaCl) as the positive and 
negative controls, respectively. Reactions were recorded based on the largest diameter (in 
millimeters) of the wheal and flare at 15 min. A SPT result was considered “positive” if the wheal 
was 3 mm or larger, without a reaction to the negative control.  
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The total serum IgE was quantified with the ImmunoCAP system (Phadia, Uppsala, Sweden). All 
the serum samples were stored at −20 °C before being used. Any sensitization was regarded as 
positive when the total IgE was greater than 0.35 kUA/L. 
  
2.3 In vitro gastroduodenal-BBM digestion of whole peanuts  
In vitro oral-gastro-duodenal digestion of peanuts was performed in triplicate, according to Minekus 
et al. 2014. Simulated salivary fluid (SSF), simulated gastric fluid (SGF), and simulated intestinal 
fluid (SIF) were prepared according to the harmonized conditions. All digestion steps were carried 
out in a shaking incubator at 37 °C and 170 rpm. For the oral phase, peanuts were grossly minced 
using a coffee grinder and 100 mg of the resulting coarse powder was suspended in 207 µL of SSF 
(included of 1500 U/mL of human salivary amylase) and incubated for 2 min. Subsequently, oral 
digesta were mixed with 320 µL SGF containing 8 µL of previously sonicated phospholipids (10 
mg/mL). The pH was adjusted to 2.7 and 40 µL of porcine pepsin (3000 U/mg) at a concentration 
of 12 mg/mL was added. Sample was incubated for 2 h at 37 °C. Pepsin hydrolysis was stopped by 
raising the pH to 7.0 with 1 M sodium bicarbonate. The duodenal digestion was carried out 2 h at 
37°C after incorporating 640 µL of SIF, bile salts (16 mg), porcine pancreatic lipase (1 mg), trypsin 
(0.7 mg, 100 U/mg as TAME activity), α-chymotrypsin (0.3 mg, 40 U/mg) and pancreatic α-
amylase (1.1 mg, 10 U/mL). A final step of intestinal digestion was performed with of BBM (13 
µU/µL, final concentration) after adjusting pH to 7.2 with 1.0 M sodium bicarbonate. After 4 h at 
37°C, peptidases were inactivated by immersion in boiling water for 5 min. Digesta were then 
filtered by Millex GV 0.22 µm (Millipore, Billerica, MA, USA) and lyophilized. 
 
2.4 Purification of peanut digesta samples 
After digestion, sample was defatted through two 10 min extraction with diethyl ether under 
magnetic stirring, followed by centrifugation at 10,000g (10 min). Large-sized polypeptides were 
precipitated with TCA up to a final concentration of 30% (w/v). After centrifugation, pellet was 
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four-fold washed with 1 mL of cold acetone, to remove residual TCA. The protein pellet was 
resuspended in 50 mM Tris-HCl, pH 7.0 and fractionated with Econo-pack 10-DG size exclusion 
chromatography (SEC) pre-packed columns (Bio-Rad), using 50 mM Tris as the eluent. Effluents 
were collected in 1 mL fractions and polypeptides monitored by the UV-absorbance at 280 nm 
(Ultrospec 160 2100 pro, Amersham Biosciences, Milan, Italy). Proteins (>6kDa) and peptide 
(MW<6 kDa) fractions were separately pooled. The low-sized peptide fraction was further desalted 
using Sep-Pak C18 pre-packed cartridges (Waters, Milford, MA, USA) washed with aqueous 0.1% 
TFA (v/v) and eluted with 70% ACN (v/v)/0.1% TFA (v/v). Proteins and peptides were 
concentrated in a speed-vac and finally lyophilized. 
 
2.5 SDS–PAGE Analysis 
Digested protein fraction >6 kDa and urea-extracted proteins were loaded onto a precast 12% 
polyacrylamide gel (Bio-Rad) either under reduction or non-reduction conditions for SDS-PAGE 
analysis. The whole protein fraction of peanuts, extracted according to Koppelman et al. 2016, was 
used as a reference to monitor the proteolysis. Proteins were visualized with blue silver (G250) 
staining. The gel was imaged with a scanner and processed using the LABScan software 3.00 
(Amersham Bioscience).  
For proteomic analysis, protein bands were manually excised, destained with acetonitrile/25mM 
Ambic (1/1, v/v) and dried under vacuum after dehydration in acetonitrile. Gel pieces were 
rehydrated with 20 µL of a 12 ng/µL trypsin solution in 50 mM Ambic for 45 min on an ice-cold 
bath. Afterward, the excess of trypsin solution was discarded and the protein bands were incubated 
overnight at 37°C. The tryptic peptides were two-fold extracted in 40 µL of 50% acetonitrile 
containing 2.5% (v/v) formic acid and dried using a speed-vac.  
 
2.6 Western blotting analysis 
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IgE binding peanut proteins were detected by immunoblot analysis, performed using a pool of sera 
from N=8 children allergic to peanuts, as the source of specific IgE. SDS-PAGE resolved proteins 
were electroblotted onto nitrocellulose membrane using a Trans-blot cell (Bio-Rad) at 120 V for 60 
min. The membrane was blocked for 1 h at room temperature with 5% (w/v) bovine serum albumin 
(Sigma-Aldrich) in a Tris-buffered saline solution with 0.05% Tween 20 (TBS-T) and incubated 
overnight at 4 °C with the pooled sera diluted 1:50 in TBS-T. After extensive washing (3 x 10 min 
with TBS-T), the membrane was incubated 1 h with monoclonal peroxidase-conjugated anti-human 
IgE antibody developed in goat (Sigma, cod. A9667), diluted 1:10000 with TBS-T. The membrane 
was rinsed with TBS-T (3 ×10 min) and finally with TBS (1 ×10 min) before development. 
Chemiluminescence reagents (ECL Plus WB reagent, GE Healthcare. Milan Italy) and X-ray film 
(Kodak, Chalons/Saône, France) were used to visualize the immunoreactive protein bands at 
various exposure times (0.5-5 min range). 
 
2.7 LC-high resolution (HR)-MS/MS analysis  
Mass spectrometry analysis was performed using a Q Exactive Orbitrap mass spectrometer (Thermo 
Scientific, San Jose, CA, USA), online coupled with an Ultimate 3000 ultra-high performance 
liquid chromatography instrument (Thermo Scientific). Samples were resuspended in 0.1% (v/v) 
formic acid solution, loaded through a 5 mm long, 300 µm i.d. pre-column (LC Packings, USA) and 
separated by an EASY-Spray™ PepMap C18 column (2 µm, 15 cm x 75 µm) 3 µm particles, 100 Å 
pore size (Thermo Scientific). Eluent A was 0.1% formic acid (v/v) in in Milli-Q water; eluent B 
was 0.1% formic acid (v/v) in acetonitrile. The column was equilibrated at 5% B. Peptides were 
separated applying a 4–40% gradient of B over 60 min. The flow rate was 300 nL/min. The mass 
spectrometer operated in data-dependent mode and all MS1 spectra were acquired in the positive 
ionization mode with an m/z scan range of 350 to 1600. Up to 10 most intense ions in MS1 were 
selected for fragmentation in MS/MS mode. A resolving power of 70,000 full width at half 
maximum (FWHM), an automatic gain control (AGC) target of 1x106 ions and a maximum ion 
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injection time (IT) of 256 ms were set to generate precursor spectra. MS/MS fragmentation spectra 
were obtained at a resolving power of 17,500 FWHM. In order to prevent repeated fragmentation of 
the most abundant ions, a dynamic exclusion of 10s was applied. Ions with one or more than six 
charges were excluded. Spectra were elaborated using the Xcalibur Software 3.1 version (Thermo 
Scientific). Mass spectra were elaborated using the Proteome Discoverer 2.1 software (Thermo 
Scientific), restricting the search to Arachis Hypogea database extracted from the NCBI 
(downloaded on March 2017).  
Database searching parameters for identification of SDS-PAGE protein bands were the following: 
Met oxidation and pyroglutamic for N-terminus Gln as variable protein modifications; 
carboxymethylcysteine as a constant modification; a mass tolerance value of 10 ppm for precursor 
ion and 0.01 Da for MS/MS fragments; trypsin as the proteolytic enzyme; missed cleavage up to 2. 
Database searching parameters for identification peptides is digests were the same described above, 
except for no modification of cysteine residues included and no proteolytic enzyme selected. 
The false discovery rate and protein probabilities were calculated by Target Decoy PSM 
Validator working between 0.01 and 0.05 for strict and relaxed searches, respectively. Proteins were 
considered confidently identified based on at least four sequenced peptides. 
 
2.8 RP-HPLC and DOT-BLOT analysis 
Peanut digests were fractionated using a HP1100 modular system (Agilent, Palo Alto, CA, USA) 
equipped with a RP-HPLC a C18 (5µ, 4.6 mm i.d., 300A, 250 mm) reverse-phase column 
(Phenomenex, Torrance, CA, USA) at a flow rate of 1 mL/min. Solvent A was 0.1%  TFA (v/v) in 
water; solvent B was 0.1% TFA in acetonitrile. Separation of the peptides was effected with a 5-
70% linear gradient of solvent B over 90 min, following 5 min of isocratic elution at 5% B. The 
column effluents were monitored at λ=214 and 280 nm using a diode-array detector.  
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For dot-blot assay, the manually collected HPLC fractions were spotted onto a 0.22-µm trans-blot 
nitrocellulose membrane (Bio-Rad) and developed using the same protocol as the Western blot 
assay. The whole protein extract was used as the positive control. 
 
 
3. Results 
3.1 Gastrointestinal digestion of whole peanut 
The stability of IgE binding proteins following gastrointestinal digestion of whole raw peanut, was 
determined by immunochemical and proteomic analysis, according to the workflow diagram shown 
in Figure 1.  
A widespread commercial variety of peanuts (Virginia cv) was used in this study (Koppelman et al. 
2016). Whole peanuts were digested according to the harmonized in vitro static digestion model 
(Minekus et al. 2014), based on the following phases: oral phase through mastication, gastric and 
duodenal phases with a sequential addition of digestive enzymes in physiological concentration 
ranges. The model was finally integrated with pig intestinal BBM mimicking the jejunal phase of 
peptide degradation. After in vitro digestion, samples were defatted and protein and peptide 
fractions were separated by SEC. 
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Fig. 1: Schematic workflow of the experimental approach employed (immunoassay and MS-based 
analysis) for the study and characterization of proteolytic digesta resulting from in vitro simulated 
digestion of whole peanuts.  
 
3.2 SDS-PAGE analysis digesta sample 
The disappearance of peanut proteins after simulated digestion was monitored by SDS-PAGE (Fig. 
2), compared with whole protein extract as the reference control of undigested proteins. Individual 
electrophoretic bands were identified by peptide sequencing using LC-MS/MS analysis, as reported 
in Table 1. Ara h 1 was identified at approximately 68.2 kDa (band 1) and as less abundant isoforms 
at 58.2 (band 2) and 33.4 kDa (band 8). Ara h 3 migrated in three different bands at 58.2  54.9 and 
52.4 kDa (band 2, 3, and 4 respectively), close to Ara h 1. Low-abundance bands identified as Ara h 
3 were detected between 52.4 and 17.2 kDa (bands 5-12). The high heterogeneity observed for Ara 
h 3 is a consequence of multiple post-translational proteolytic events, involving the N-terminal of 
the acidic subunit, which produces isoforms of various molecular size (Piersma et al. 2005). A 
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similar processing has already been described for 11S glycinin storage proteins from other plant 
sources (Dickinson et al. 1989). The Ara h 2 migrated as a doublet at 17.8 (band 11) and 17.2 kDa 
(band 12) which were assigned to the Ara h 2.01 and Ara h 2.02 isoforms, respectively, according 
to migration (Koopelman et al. 2010). The Ara h 6 was identified as a well resolved band at 16.3 
kDa (band 13). Minor allergens Ara h 7, Ara h 8 and Ara h 10 were also detected in band 12.  
As expected, after gastrointestinal digestion of whole peanuts, the electrophoretic protein pattern 
radically changed, since large-sized proteins were no longer detectable, while the gel exhibited 
multiple polypeptide fragments at MW estimated between 7 and 23 kDa (Fig. 1). MS/MS-based 
analysis revealed the presence of Ara h 3 fragments in all these bands (bands 14-17), indicating that 
large domains of Ara h 3 survived proteolytic degradation. Ara h 6 fragments were detected in band 
16 and 17, whilst practically intact residual Ara h 2 was revealed exclusively in band 15. No signal 
assigned to Ara h1 allergen was detected in the gel, confirming its susceptibility to digestion leading 
to low MW peptide products (Koopelman et al. 2010). 
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Fig. 2: SDS-PAGE comparison of undigested and digested peanut proteins under non-
reducing conditions. Lane 1, molecular marker. Lane 2, whole peanut protein extract (urea 
extract). Lane 3, protein extract obtained from in vitro simulated gastrointestinal digestion of whole 
peanuts.  
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Table 1: Identification of protein bands from SDS-PAGE through LC-HR-MS/MS of in gel produced tryptic peptides (Fig. 2). 
 
Banda  Accession Description Allergen nameb Coveragec Peptidesd aae MW [kDa]f calc. pIf Score Sequest HTg 
Peptides 
SEQUEST 
HTh 
B
e
f
o
r
e
 
d
i
g
e
s
t
i
o
n
 
 
1 N1NG13 Seed storage protein Ara h1  Ara h 1 65 64 626 71,302 7,06 689,59 64 
2 
Q8LKN1 Allergen Arah3/Arah4  Ara h 3 73 32 538 61,7 5,72 489,49 32 
N1NG13 Seed storage protein Ara h1  Ara h 1 59 43 626 71,302 7,06 266,06 43 
3 Q647H3 Arachin Ahy-2  Ara h 3 56 31 537 61,494 5,73 499,05 31 
4 Q647H3 Arachin Ahy-2  Ara h 3 55 25 537 61,494 5,73 182,64 25 
5 Q647H3 Arachin Ahy-2  Ara h 3 50 23 537 61,494 5,73 205,92 23 
6 Q8LKN1 Allergen Arah3/Arah4  Ara h 3 47 18 538 61,7 5,72 116,78 18 
7 Q9FZ11 Gly1  Ara h 3 58 27 529 60,412 5,64 225,42 27 
8 
A1DZF0 Arachin 6  Ara h 3 48 24 529 60,339 5,54 336,71 24 
N1NG13 Seed storage protein Ara h1  Ara h 1 43 26 626 71,302 7,06 137,80 26 
9 A1DZF0 Arachin 6  Ara h3 33 18 529 60,339 5,54 94,68 18 
10 A1DZF0 Arachin 6  Ara h 3 59 32 529 60,339 5,54 356,90 32 
11 
Q6PSU2 Conglutin-7  Ara h 2 40 5 172 20,102 6,34 31,61 5 
Q647G5 Oleosin 1  Ara h 10 27 3 169 17,741 9,58 15,39 3 
12 
A1DZF0 Arachin 6  Ara h 3 33 15 529 60,339 5,54 77,368 15 
Q6PSU2 Conglutin-7  Ara h 2 36 5 172 20,102 6,34 41,520 5 
Q647G5 Oleosin 1  Ara h 10 36 6 169 17,741 9,58 23,170 6 
B0YIU5 Ara h 8 allergen isoform  Ara h 8 38 3 153 16,402 5,2 16,86 3 
B4XID4 Ara h 7 allergen  Ara h 7 26 3 164 19,326 7,9 9,83 3 
13 A5Z1R0 Ara h 6  Ara h 6 61 9 145 16,909 6,52 60,31 9 
A
f
t
e
r
 
d
i
g
e
s
t
i
o
n
 
 
14 Q9FZ11 Gly1  Ara h 3 32 12 529 60,412 5,64 33,78 12 
15 Q5I6T2 Arachin Ahy-4  Ara h 3 32 14 531 60,699 5,48 56,624 14 
52001227 2S protein  Ara h 2 46 11 179 20,837 7,36 52,84 11 
16 Q9FZ11 Gly1  Ara h 3 34 15 529 60,412 5,64 64,41 15 
A5Z1R0 Ara h 6  Ara h 6 57 11 145 16,909 6,52 62,38 11 
17 Q9FZ11 Gly1  Ara h 3 18 8 529 60,412 5,64 42,81 8 
A5Z1R0 Ara h 6  Ara h 6 52 8 145 16,909 6,52 29,11 8 
a Protein band from SDS-PAGE (Fig. 2); b allergen name according to WHO/IUIS database (www.allergen.org); c sequence coverage (%); d number 
of peptides identified; e number of amino acids (AA), f theoretical Mr and pI values; g sum of the scores of the individual peptides from the Sequest 
HT search; I umber of distinct peptide sequences in a protein group from the SEQUEST HT search. 
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3.3 Western blotting of digesta sample 
The IgE-reactivity of digested and undigested peanut proteins was assayed by immunoblotting 
using pooled sera from eight pediatric patients diagnosed with food allergy to peanut (Fig. 3). 
Before digestion, almost all the major peanut proteins appeared as IgE-reactive, mainly due to the 
individual heterogeneity in the recognition patterns of the allergic subjects. Consistently with SDS-
PAGE, native allergens were no longer detectable in gastrointestinal digests, while neo-formed low 
MW bands were immunoreactive. The immunoreactive band at 23.0 kDa was identified from the 
corresponding Coomassie stained electrophoretic gel (Fig. 1, Table 1) as Ara h 3 fragments. The 
IgE-binding fragments in the immunoreactive bands between 20 and 7 kDa were not univocally 
assigned, due to co-migration of fragments arising from Ara h 2, Ara h 3 and Ara h 6. 
 
Fig. 3: Western Blotting analysis. Undigested (lane 1) and digested (lane 2) peanut extracts 
immunostained using specific IgE from pooled sera of (N=8) pediatric allergic subjects.  
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3.4 LC-MS/MS analysis of digesta sample 
The peptide fraction of digested samples collected after SEC separation (see Figure 1) was analyzed 
by LC-HR-MS/MS to identify the released peptides resistant to digestion. Table 2 lists the parent 
proteins identified through MS/MS based peptide sequencing. Details about peptide sequences are 
reported in Table S2. Figure 4 highlights the sequence of peptides identified in the digesta 
belonging to Ara h 1, Ara h 3, Ara h 2 and Ara h 6 main isoforms. Notably, protein coverage data 
generated by peptide sequencing, might be not fully exhaustive, considering that database search is 
challenged by the non-tryptic nature of the peptides, the non predictable cleavage specificity as well 
as the extreme heterogeneity of the parent protein subset. Despite such drawbacks, LC-HR-MS/MS 
analysis revealed a heterogeneous mixtures of peptides (nearly 800 identified sequences) with 
molecular size up to 5000 kDa. The bulk of signals was assigned to fragments of Ara h 3 isoforms, 
which mapped 69% of the primary structure, indicating a significant stability of Ara h 3-derived 
peptides to gastrointestinal protease.  
A lower number of peptides (MW between 400 and 2000 Da) matched with Ara h 1, showing a 
sequence coverage of 22%. Peptides arising from Ara h 2 and Ara h 6 digestion were detected as 
well. In particular, two and five peptides from Ara 6 and Ara h 2 were identified, respectively. 
Similarly, six peptides attributed to Ara h 8, occurred in the peptide mixture. Proteolytic fragments 
of actin, conarachin, 13-lipoxigenase were also detected, though with poor sequence coverage. 
Three peptides arising from the digestion of an olesin allergen, namely Ara h 10, were identified as 
well. As regarding these hydrophobic proteins, we can not exclude that large oleosin-derived 
peptides remained embedded in the lipid matrix and were removed during defatting process of 
digesta.  
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Fig. 4: Primary  sequences of  the major peanut allergens Ara h 1, Ara h 3, Ara h 2 and Ara h 6. The  
highlighted domains correspond to peptides arising from simulated digestion of whole peanut, 
identified by LC-HR-MS/MS. The underlined sequences belonging to Ara h 1 and Ara h 3 
correspond to predicted IgE-binding regions. The boxed sequences are Ara h 3 IgE-binding peptides 
as assessed by Dot-blot and LC-HR-MS/MS.  
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Table 2: Identification of parent peanut proteins through LC-HR-MS/MS sequencing of peptide digests 
Accession Description 
Allergen 
namea Coverageb Peptides c aad MW [kDa]e calc. pIe 
Score 
SEQUEST 
HTf 
Peptides 
SEQUEST 
HTg 
Q5I6T2 Arachin Ahy-4  Ara h 3 69 403 531 60,69 5,48 6531 403 
Q9FZ11 Gly1  Ara h 3 69 392 529 60,41 5,64 6523 392 
B5TYU1 arachin Arah3 isoform  
Ara h 3 69 346 530 60,58 5,55 5560 346 
A1DZF0 arachin 6  Ara h 3 69 356 529 60,33 5,54 5925 356 
Q0GM57 iso-Ara h3  Ara h 3 69 260 512 58,22 5,59 3464 260 
P02872 peanut agglutinin precursor  
Ara h 
agglutinin  35 25 273 29,30 5,66 224 25 
B0YIU5 Ara h 8 allergen isoform  
Ara h 8 69 6 153 16,40 5,2 41 6 
A0A0A1EUV7 actin  25 15 323 35,86 5,97 168 15 
N1NG13 Seed storage protein Ara h1  
Ara h 1 22 41 626 71,30 7,06 630 41 
B3IXL2 Main allergen Ara h1  
Ara h 1 22 35 614 70,24 6,86 554 35 
Q647H1 Conarachin   20 28 662 75,88 5,4 232 28 
Q647H2 Arachin Ahy-3  Ara h 3 18 16 484 54,53 5,59 130 16 
Q6PSU2 
 
 
seed storage 
protein SSP1  
Ara h 2 
16 5 187 21,77 6,39 56 5 
          
Q647G5 oleosin 17.8  Ara h 10 13 3 169 17,74 9,58 8 3 
Q647G9 Conglutin  Ara h 6 7 2 145 16,91 6,01 36 2 
A1DZE9 Conglutin 8 hypogaea  
Ara h 6 7 3 145 16,82 6,54 20 3 
Q4JME6 13-lipoxygenase   3 5 863 97,41 5,53 28 5 
 
a allergen name according to WHO/IUIS database (www.allergen.org); b sequence coverage (%); c number of peptides identified; d number of amino 
acids (AA), e theoretical MW and pI values; f sum of the scores of the individual peptides from the SEQUEST HT search; g number of distinct 
peptide sequences in a protein group from the SEQUEST HT search. 
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3.5 Characterization of IgE binding peptides 
IgE binding capability of peptides (<6kDa) was assessed by HPLC fractionation and Dot-blot 
analysis (Fig. 5a and 5b). Six out of sixteen spotted fractions (panel B) tested positive to IgE. 
Fractions 9, 10, 12, 13 and 16 exhibited the most intense response, indicating the presence of 
peptide(s) harboring IgE epitope(s). Fraction 5, 8 and 14 were also positive, although at a weaker 
intensity. IgE positive-HPLC fractions were sequenced by LC-HR-MS/MS (Table 3). Details about 
MS/MS based peptide sequencing are given in Table S3. The reference linear IgE-binding epitopes 
are taken from previous studies (Rabjohn  et al. 1999, Rougé et al. 2009, Jin et al. 2009, Shinmoto 
et al. 2010). Overall, IgE-binding peptides were from Ara h 3, releasing three specific domains that 
appear particularly resistant to proteolysis (Fig. 4, boxed regions). In the HPLC peaks 12 and 13, 
“chopped” forms of a single peptide deriving from the protein region 260-274 (referred to amino 
acid sequences of Q5I6T2) (Fig.4) harbored the epitope GNIFSGFTPEFLEQA (Rabjohn P. et al 
1999, Jine et al 2009). The same epitope was also encrypted in peptides arising from Ara h 3 
isoform (Q9FZ11), where an alanine is replaced by a glutamic acid residue 
(GNIFSGFTPEFLAQA) (Table 3). In contrast, the HPLC peaks 8, 9 and 10 contained peptides 
from Ara h 3 isoforms encrypting the IgE-binding epitope KNNNPFKFFVPP (Rougé et al. 2009). 
Partial sequences of a further Ara h 3 linear epitope (KKNIGRNRSPDIYNP), identified by Rouge 
et al 2009, eluted in the HPLC peaks 14 and 16. Finally, the N-terminal fragment of Ara h 3 
harboring the IgE-binding epitope IETWNPNNQEFECAG (Rabjohn et al 1999) occurred in 
fraction 5. Noteworthy, exclusively Ara h 3 fragments were IgE-positive, whilst no immunoreactive 
peptide of Ara h 1 was identified.  
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Fig. 5: HPLC fractionation (A) and dot-blot analysis of individual fractions (B) of low MW 
peptides (<6kDa) arising from simulated digestion of whole raw peanut. IgE-immunoreactive 
peptides were identified by LC-HR-MS/MS. 
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Table III: Sequences harbouring IgE binding peptides, identified in IgE-immunoreactive HPLC 
fractions (Figure 5). Details about MS/MS based peptide sequencing are reported in Table S1. 
 
Accession Amino acid sequence LC MH+(Da) 
Q647H3; 
Q9FZ11 
LNAQRPDNRLESEGGYIETWNPNN #5 2787.30979 
Q8LKN1; 
Q647H4;Q6IW
G5; Q9SQH7; 
Q5I6T2;. 
LNAQRPDNRIESEGGYIETWNPNN #5 2787.30979 
Q647H4. NRSPDIYNPQAGSLKTANELNLLILR #8 2910.57749 
Q9SQH7 QLKNNNPFKFFVPPFQQSPR 
--KNNNPFKFFVPPFQQSPR 
#8 2416.25553 
2192.13993 
Q647H3; 
Q5I6T2 
 
NRSPDIYNPQAGSLKTANDLNLLIL- 
NRSPDIYNPQAGSLKTANELNLLILR 
#9 2740,46281 
2910,57957 
Q647H3; 
Q5I6T2 
QLKNNNPFKFF-------- 
-------FKFFVPPFQQSP 
----NNPFKFFVPP----- 
#10 1379,71064 
1468,76234 
1206,63060 
Q9SQH7; 
Q5I6T2 
AGQEEENEGGNIFSGFTPEFLEQAFQVDDR---- 
---EEENEGGNIFSGFTPEFLEQAFQVDDR----                       
-------EGGNIFSGFTPEFLEQAFQVDDRQIVQ 
----EENEGGNIFSGFTPEFLEQAFQVDDR---- 
-----ENEGGNIFSGFTPEFLEQAFQVDDR---- 
------NEGGNIFSGFTPEFLEQAFQVDDR---- 
-------EGGNIFSGFTPEFLEQAFQVDDR---- 
#12 3360.50791 
3104.37456 
3071.47702 
2975.33585 
2846.28862 
2717.23686 
2603.20561 
Q8LKN1; 
Q647H3; 
Q647H4 
AGQEQENEGGNIFSGFTPEFLAQAFQVDDR----  
AGQEQENEGGNIFSGFTPEFLAQAF--------- 
#12 3301.50290 
2688.22197 
Q6IWG5; 
Q9SQH7 
QLKNNNPFKFFVPPFQQSPR 
QLKNNNPFKFFVPPF----- 
#12 2416.24857 
1819.95452 
Q5I6T2; 
Q9SQH7 
---EEENEGGNIFSGFTPEFLEQAFQVDDRQIVQNLRGE- 
----EENEGGNIFSGFTPEFLEQAFQVDDRQIVQNLRGE-            ----
EENEGGNIFSGFTPEFLEQAFQVDDRQIVQNLR---                                      -------
EGGNIFSGFTPEFLEQAFQVDDRQIVQNLRGEN                  -------
EGGNIFSGFTPEFLEQAFQVDDRQIVQNLRGE-                     -------
EGGNIFSGFTPEFLEQAFQVDDRQIVQNLR--- 
----EEDEGGNIFSGFTPEFLEQAFQVDDR---------- 
----EENEGGNIFSGFTPEFLEQAFQV-------------                     -------
EGGNIFSGFTPEFLEQAFQVD------------                 
#13 4141.91421 
4012.89492 
3826.81826 
3754.80979 
3640.76406 
3454.71054 
2976.32573 
2589.17803 
2332.08745 
Q8LKN1; 
Q647H3; 
Q647H4; 
Q9FZ11. 
AGQEQENEGGNIFSGFTPEFLAQAFQVDDRQIL------- 
----EENEGGNIFSGFTPEFLAQAFQVDDRQIVQNLRGEN            ----
EENEGGNIFSGFTPEFLAQAFQVDDRQIVQNLRGE- 
----EENEGGNIFSGFTPEFLAQAFQVDDRQIVQNLR---                -------
EGGNIFSGFTPEFLAQAFQVDDRQILQ 
----QENEGGNIFSGFTPEFLAQAF--------------- 
-------EGGNIFSGFTPEFLAQAF--------------- 
#13 3655.73288 
4068.92885 
3954.88588 
3768.84463 
3027.48223 
2286.03105 
1931.92278 
Q647H4. KKNIGRNRSPDIYNPQAGSLKTANELNLLILRWL 
-KNIGRNRSPDIYNPQAGSLKTANELNLLILRWL 
--NIGRNRSPDIYNPQAGSLKTANDLNLLILRWL 
-----RNRSPDIYNPQAGSLKTANDLNLLILRWL 
------NRSPDIYNPQAGSLKTANDLNLLILRWL------ 
#13 3906.18349 
3778.09853 
3635.97622 
3351.82325 
3195.73061 
Q6IWG5; 
Q647H4. 
NRSPDIYNPQAGSLKTANELNLLILRWL 
NRSPDIYNPQAGSLKTANELNLLIL--- 
NRSPDIYNPQAGSLKTANELNL------ 
#14 3209.73337 
2754.48044 
2415.22611 
Q647H4;  
Q647H3; 
Q9FZ11; 
Q5I6T2 
NRSPDIYNPQAGSLKTANELNLLILRWLGLSAEYGNLYR 
NRSPDIYNPQAGSLKTANDLNLLILRWLGLSAEYGNLYR 
NRSPDIYNPQAGSLKTANDLNLLILRWLGLSAEYGNLY- 
--SPDIYNPQAGSLKTANDLNLLILRWLGLSAEYGNLYR 
NRSPDIYNPQAGSLKTANELNLLILRWLGLSAEYG---- 
NRSPDIYNPQAGSLKTANDLNLLILRWLGL--------- 
NRSPDIYNPQAGSLKTANELNLLILRWL----------- 
NRSPDIYNPQAGSLKTANDLNLLILRWL----------- 
#16 4433.33387 
4419.32294 
4263.21840 
4149.17348 
3887.04555 
3365.84731 
3209.74209 
3195.71914 
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Discussion 
The mechanism by which dietary proteins sensitize and elicit an allergic reaction remains 
substantially unresolved. In particular it is still fervently debated whether gastrointestinal digestion 
stability could be an effective predictor of allergenicity. Anyway, it is widely accepted that many 
among the most common food allergens are digestion resistant proteins and probably induce 
sensitization at the level of the intestinal tract (Asero and Antonicelli 2011). Unquestionably, the 
digestion stability increases the probability that a food protein (or its derived peptide) can sensitize 
an individual, because in addition to the skin, respiratory and oral mucosa ones, also the intestinal 
route of sensitization becomes accessible. In the last years, the scientific community has paid 
remarkable attention to the evaluation of the stability of food allergens along the human digestive 
tract, also providing information at the molecular level about the proteolytic fraction resulting from 
the digestion process (Huby et al. 2000). In a perspective of molecular resolved diagnostic and 
therapeutic approaches, these insights contribute to the precise identification of epitopic 
determinants able to reach the intestinal mucosa in immunological active form, with relatively high 
likelihood to trigger immunological reactions in sensitised subjects. To this aim, more or less 
physiological-correspondent in vitro protocols have been developed to simulate human digestion. 
Early attempts evaluated the digestion stability of purified allergens by mimicking only the gastric 
phase of digestion (Astwood et al. 1996). Later on, digestion protocols were extended also to the 
pancreatic phase (Fu et al. 2002, Wickham et al. 2009). In the case of peanuts, nearly all model 
studies indicated that Ara h 1 and Ara h 3 are broken down into small peptide fragments within 
minutes, while Ara h 2 and Ara 6 remain almost unaffected by digestion (Koopelman et al. 2010). 
The digestion resistance might justify the predominant clinical relevance of Ara h 2 and Ara h 6 
allergens (Flinterman et al, 2007). At the same time, these outcomes left partially unanswered the 
question why and how extremely proteolysis-labile proteins, such as as Ara h 1 and Ara h 3, could 
be associated with primary sensitization.  
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The digestion and the immunogenic potential of allergenic proteins in a more realistic 
context, also taking into consideration the allergen containing food matrix, have remained poorly 
investigated so far. In this paper, we aimed at investigating the stability of peanut allergens 
throughout the digestive process and at identifying the potential antigenic determinants surviving 
the digestion. However, compared to the existing works, which are for the most tailored to the 
assessment of allergen stability using standard purified proteins, we herein introduced a further 
complexity factor represented by the whole peanut matrix to reproduce more realistically what 
happens after consumption of peanuts. To this purpose, we applied the harmonized in vitro 
digestion procedure, developed for mimicking protein degradation of unfractionated foodstuff 
(Minekus et al. 2014). This digestion model was also integrated with an additional step with porcine 
jejunal BBM enzymes. The jejunal phase of peptide degradation is a fundamental step for assessing 
the intestinal stability of large protein fragments produced upstream, during the gastric and 
duodenal phases (Mamone et al. 2007, Picariello et al. 2016).  
In line with previous studies (Apostolovic et al. 2016), the outcomes of the digestion assays 
confirmed the substantial stability of Ara h 2 and Ara h 6, since these latter produced protein 
fragments with MW only slightly lower than their parent proteins, as detected by SDS-PAGE. 
Consistently, LC-HR-MS/MS of the small MW peptides revealed that Ara h 2 and Ara h 6 released 
a  number of peptides relatively low.  
The most striking result of the current study was the additional identification of digestion stable Ara 
h 3 large sized fragments (7-21 kDa). Such a finding contrasts with most of the previous literature, 
which claimed the almost complete susceptibility of Ara h 3 to gastrointestinal proteases 
(Koppelman et al. 2010). The partial resistance of Ara h 3 to digestion was also confirmed by LC-
HR-MS/MS analysis of peptide digests, that contained several peptides with MW between 800 and 
5000 Da mapping the Ara h 3 isoforms for 69% overall. A reasonable explanation of this finding 
may be the “masking effect” by the peanut matrix, delaying or impairing the protein degradation and 
altering the pattern of the peptide fragments released by proteolysis. Indeed, the peanut body 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
includes a medium protein content and high level of lipids and polysaccharides, which may affect 
the proteolysis, sparing several immunological active polypeptides. It has been demonstrated that 
some type of polysaccharides decrease the digestibility of peanut allergens and increased the 
number of large-sized IgE-binding polypeptides (Mouencoucon et al. 2004). Similarly, reports 
assessing digestion stability of other food allergens (e.g. β-lactoglobulin, Act d 2 kiwi allergens, β-
conglycinin) confirmed this trend (Mouencoucon et al. 2004, Polovic et al. 2007, De Angelis et al. 
2017). The presence of lipids, like phospholipids naturally occurring in foods may greatly alter 
susceptibility of allergens to digestion, as well. For example, phosphatidylcholine hinders the 
enzymatic degradation of β-lactoglobulin and α-lactalbumin (Moreno et al. 2005, Mandalari et al. 
2009).  
In addition to proteins, we evaluated the IgE-binding properties of peptides resulting from simulated 
digestion. By using a combined approach based on HPLC, dot-blot and LC-HR-MS/MS, for the 
first time, to the best of our knowledge, it was evaluated the IgE-binding property of peptide 
fragments produced as a consequence of the physiological digestion. Interestingly, linear epitopes 
GNIFSGFTPEFLEQA and IETWNPNN encrypted in digestion-stable Ara h 3 domains were 
sequenced. Their epitope nature had previously been assessed using overlapping synthetic peptides 
(Rabjohn et al. 1999) and their conformation within native Ara h 3 protein was determined by 
crystallographic methods (Jin et al. 2009). Notably, it has been reported that the side chain of 
GNIFSGFTPEFLEQA and IETWNPNN was nearly completely buried in the folded native allergen, 
thereby being not exposed to the IgE capture (Jin et al. 2009). However, as suggested by the same 
authors and confirmed in current study, the Ara h 3 peptides harboring these epitopes became 
available for interaction with immune system effectors upon gastrointestinal release. These same 
authors also identified two additional linear Ara h 3 epitopes (DEDEYEYD and 
VTVRGGLRILSPDRK) that, on the contrary, are exposed on the surface of the allergen in the 
native folding and so immediately available for IgE-binding. Although peptides containing these 
epitopes occurred in the peanut digesta (Fig. 4, Table S1), none of them was IgE-immunoreactive in 
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our conditions. This apparent incongruence is likely due to a poor specificity of these epitopes for 
the specific IgE in the pool of pediatric sera used in the current study. To this purpose, it has to be 
underlined that IgE-based immunochemical assays for the identification of allergenic determinants 
are in general affected by a high degree of individual variability. 
Unlike Ara h 3, Ara h 1 was completely degraded and no derived peptide showed 
immunoreactivity. LC-HR-MS/MS analysis of digesta revealed Ara h 1 peptides with MW lower 
than 2kDa, which mapped 22 % of the whole protein. Although some of the Ara h 1 sequenced 
peptides included already described epitopes (Fig. 4, Table S3), these were not reactive against 
serum IgE in our conditions. Bøgh et al. 2009 demonstrated that gastro-duodenal digests from Ara h 
1, containing peptides of size less than 2 kDa, could induce degranulation response with a similar 
magnitude as intact Ara h 1. These small peptides were shown to be aggregated in large complexes, 
which was hypothesized to be the reason for their eliciting capacity (Bøgh et al. 2009). 
 
 
5. Conclusion 
Our results point out the importance to investigate the digestion process of whole food, instead of 
purified allergen proteins, clearly increasing the correspondence of the model systems with human 
physiology. Remarkably, at the moment a digestion model assuring the complete in vitro-in vivo 
correspondence is not available, taken into account the large range of factors affecting human 
digestion and the complexity of an ordinary meal. Notwithstanding this, a static in vitro multi-
compartmental model, recently developed in the framework of the EU Infogest Cost Action with 
the precise aim to harmonize digestion conditions based on human physiology, has been applied for 
the evaluation of allergen stability of food matrices (Picariello et al. 2015, Mamone et al. 2015), 
providing physiologically consistent outcomes (Egger et al. 2016). Along with the advancement of 
omic sciences, it is plausible to assume that all products arising from food digestion can be “simply” 
characterized in order to define with high accuracy the metabolic fate of either toxic or bioactive 
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molecules. With regard to food allergens, improving the understanding of the spatio-temporal 
evolution of allergens in the gastrointestinal tract will facilitate the development of more sensitive 
and effective antibodies to detect food allergens, pushing to the edge the limit of allergen detection 
in complex matrices, and will support establishing threshold levels of sensitization/elicitation. In 
perspective, such an analysis could contribute to predict the allergenicity of proteins from novel and 
alternative foods. 
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• A realistic picture of the potentially allergenic peanuts is provided.  
• Large fragments of Ara h 3, survive to in vitro gastrointestinal digestion; 
• Ara h 3 IgE binding epitopes  are released during gastrointestinal digestion.  
• Ara h 1 is completely degraded following in vitro gastrointestinal digestion. 
• Peanut matrix slows the gastrointestinal digestion process of allergen proteins.  
 
